Vanderbilt-Ingram Cancer Center Archive — Page 9 of 27
-
January 5, 2024
Artificial intelligence advances work in VUMC’s clinical and research settings
Vanderbilt University Medical Center physicians and researchers are applying artificial intelligence in innovative ways to advance clinical care and scientific understanding of these cutting-edge tools. -
January 4, 2024
VUMC in the news, Jan. 9, 2024
-
January 4, 2024
Potential AML therapy induces leukemic stem cell death
Vanderbilt researchers are studying a potential therapy for acute myeloid leukemia that targets the residual leukemic stem cells in bone marrow after treatment that are responsible for relapses and drug resistance. -
December 20, 2023
Appointments, additions in 2023 strengthen VUMC’s core missions
During the past year, multiple new appointments and additions strengthened VUMC’s core missions. -
December 15, 2023
Clinical trial shows efficacy for atezolizumab combined with carboplatin
-
December 14, 2023
Sam S. Chang recognized by the American Urological Association
The American Urological Association has announced that Vanderbilt's Sam S. Chang, MD, MBA, is one of its 2024 award recipients. -
November 30, 2023
Ukrainian oncologists visit Vanderbilt-Ingram Cancer Center
A group of Ukrainian oncologists recently visited Vanderbilt-Ingram Cancer Center where they toured research labs, observed tumor board meetings, met with several Vanderbilt oncologists, and attended the 23rd Annual Retreat for Cancer Biology.